Novocure Ltd (NVCR) SEC Filings — 2024
22 SEC filings for Novocure Ltd (NVCR) in 2024.
Filings
- NovoCure Files 8-K/A Amendment — 8-K/A · Dec 17, 2024
- NovoCure Files 8-K with Corporate Updates — 8-K · Dec 2, 2024
- NovoCure Ltd Files Q3 2024 10-Q Report — 10-Q · Oct 30, 2024
- NovoCure Ltd Files 8-K with Corporate Details — 8-K · Oct 15, 2024
- NovoCure Announces Leadership Changes — 8-K · Sep 3, 2024
- NovoCure Ltd Files 2024 Q2 10-Q Financial Report — 10-Q · Jul 25, 2024
- Novocure Ltd SC 13G/A Filing — SC 13G/A · Jul 10, 2024
- Novocure Ltd SC 13G/A Filing — SC 13G/A · Jul 8, 2024
- NovoCure Ltd. Announces Board Changes and Filings — 8-K · Jun 10, 2024
- NovoCure Files 8-K: Regulation FD & Exhibits — 8-K · May 20, 2024
- NovoCure Files Q1 2024 Report, Meets Filing Requirements — 10-Q · May 2, 2024
- NovoCure Ltd Files Definitive Proxy Statement — DEF 14A · Apr 22, 2024
- NovoCure Files 8-K for Reg FD and Financials — 8-K · Mar 27, 2024
- NovoCure Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- Novocure Ltd SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends NovoCure Stake, Updates Passive Holdings — SC 13G/A · Feb 9, 2024
- Capital International Investors Updates NovoCure Stake — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Report 14.937% Stake in NovoCure Ltd. — SC 13G/A · Feb 9, 2024
- NovoCure Files 8-K: Routine Corporate Update, Non-EGC Status Confirmed — 8-K · Jan 18, 2024
- NovoCure Confirms Nasdaq Listing for Ordinary Shares — 8-K · Jan 9, 2024
- NovoCure Files 8-K on Financial Condition & Operations — 8-K · Jan 8, 2024
- NovoCure Reports Executive Changes & Compensation on Jan 4 — 8-K · Jan 4, 2024